{
    "id": 29161,
    "fullName": "ERBB2 N813D",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) N813D lies within the protein kinase domain of the Erbb2 (Her2) protein (UniProt.org). N813D has been identified in the scientific literature (PMID: 29215816), but has not been biochemically characterized, and therefore its effect on Erbb2 (Her2) protein function is unknown (PubMed, Sep 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 13479,
                    "pubMedId": 29215816,
                    "title": "Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29215816"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "N813D",
    "createDate": "01/04/2019",
    "updateDate": "09/28/2019",
    "referenceTranscriptCoordinates": {
        "id": 177830,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39724855A>G",
        "cDna": "c.2437A>G",
        "protein": "p.N813D",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15610,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, Gilotrif (afatinib) treatment resulted in partial response in a patient with lung adenocarcinoma harboring ERBB2 (HER2) N813D (PMID: 30149884; NCT02979821).",
            "molecularProfile": {
                "id": 31097,
                "profileName": "ERBB2 N813D"
            },
            "therapy": {
                "id": 623,
                "therapyName": "Afatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 13478,
                    "pubMedId": 30149884,
                    "title": "Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30149884"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31097,
            "profileName": "ERBB2 N813D",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177831,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39724855A>G",
            "cDna": "c.2437A>G",
            "protein": "p.N813D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177830,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39724855A>G",
            "cDna": "c.2437A>G",
            "protein": "p.N813D",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}